Benefits
DashboardNot registered yet? Get a free account.
Sign UpNot registered yet? Get a free account.
Sign Up
You're about to leave our website and go to an external link. Are you sure?
Orbion Pharmaceuticals Private Limited, is an unlisted private company incorporated on 31 May, 2021. It is classified as a private subsidiary of a foreign company and is located in Chennai, Tamil Nadu. It's authorized share capital is INR 175.00 cr and the total paid-up capital is INR 175.00 cr.
Orbion Pharmaceuticals's operating revenue range is INR 1 cr - 100 cr for the financial year ending on 31 March, 2022.
Read more
Buy Dashboard using Credits
This action will use 1 of your credits. Are you sure you want to go ahead?
Credits Balance:
0
** All rupee values in INR crores. Based on March 2024 numbers.
94.86%
322.69%
-9.16%
16.61%
-9.26
2.52
2.89
-3.97
4.04
0.21
Buy Report or Plans
Company dashboard
Five year financials and ratios
Risk analysis
Interactive charts
Latest financials
Latest annual return
MoA and AoA
* GST not included
** Reports & MCA filings will be based on the latest available financials.
India
(2)
| State | Type | Address |
|---|
Locations on Map
Filter (4)
Severe Risk
Moderate Risk
Low Risk
Read more
| Mar 2022 | Mar 2023 | Mar 2024 | |
|---|---|---|---|
| Sales | GET PRO | GET PRO | GET PRO |
| Operating profit | GET PRO | GET PRO | GET PRO |
| Net profit | GET PRO | GET PRO | GET PRO |
| Gross margin | GET PRO | GET PRO | GET PRO |
| Operating margin | GET PRO | GET PRO | GET PRO |
| Net margin | GET PRO | GET PRO | GET PRO |
| Networth | |||
| Borrowings | GET PRO | GET PRO | GET PRO |
| Assets | GET PRO | GET PRO | GET PRO |
| Debt to equity | GET PRO | GET PRO | GET PRO |
| Current ratio | GET PRO | GET PRO | GET PRO |
| ROE | GET PRO | GET PRO | GET PRO |
| Days payable | GET PRO | GET PRO | GET PRO |
| WC days | GET PRO | GET PRO | GET PRO |
| Mar 2022 | Mar 2023 | Mar 2024 | |
|---|---|---|---|
| Equity Capital | GET PRO | GET PRO | GET PRO |
| Reserves | GET PRO | GET PRO | GET PRO |
| Borrowings + | GET PRO | GET PRO | GET PRO |
| Long term borrowings | GET PRO | GET PRO | GET PRO |
| Short term borrowings | GET PRO | GET PRO | GET PRO |
| Trade payables + | GET PRO | GET PRO | GET PRO |
| Days payable | GET PRO | GET PRO | GET PRO |
| Other liabilities + | GET PRO | GET PRO | GET PRO |
| Other non-current liabilities | GET PRO | GET PRO | GET PRO |
| Other current liabilities | GET PRO | GET PRO | GET PRO |
| Total liabilities | GET PRO | GET PRO | GET PRO |
| Fixed Assets + | GET PRO | GET PRO | GET PRO |
| Tangible assets | GET PRO | GET PRO | GET PRO |
| CWIP | GET PRO | GET PRO | GET PRO |
| Intangible assets | GET PRO | GET PRO | GET PRO |
| LT loans and advances | GET PRO | GET PRO | GET PRO |
| Other non-current assets | GET PRO | GET PRO | GET PRO |
| Current assets + | GET PRO | GET PRO | GET PRO |
| Inventories | GET PRO | GET PRO | GET PRO |
| Trade receivables | GET PRO | GET PRO | GET PRO |
| Cash and cash equivalents | GET PRO | GET PRO | GET PRO |
| ST loans and advances | GET PRO | GET PRO | GET PRO |
| Other current assets | GET PRO | GET PRO | GET PRO |
| Total assets | GET PRO | GET PRO | GET PRO |
| Mar 2022 | Mar 2023 | Mar 2024 | |
|---|---|---|---|
| Sales + | GET PRO | GET PRO | GET PRO |
| Sales growth % | GET PRO | GET PRO | GET PRO |
| Expenses + | GET PRO | GET PRO | GET PRO |
| Cost of goods | GET PRO | GET PRO | GET PRO |
| Employee cost | GET PRO | GET PRO | GET PRO |
| Other costs | GET PRO | GET PRO | GET PRO |
| Operating profit + | GET PRO | GET PRO | GET PRO |
| Operating margin % | GET PRO | GET PRO | GET PRO |
| Other income | GET PRO | GET PRO | GET PRO |
| Interest | GET PRO | GET PRO | GET PRO |
| Depreciation | GET PRO | GET PRO | GET PRO |
| Exceptional items | GET PRO | GET PRO | GET PRO |
| Profit before tax | GET PRO | GET PRO | GET PRO |
| Tax | GET PRO | GET PRO | GET PRO |
| Profit - disc. ops | GET PRO | GET PRO | GET PRO |
| Net profit | GET PRO | GET PRO | GET PRO |
| Net margin % | GET PRO | GET PRO | GET PRO |
| Mar 2022 | Mar 2023 | Mar 2024 | |
|---|---|---|---|
| Solvency + | |||
| Total Debt/Equity | GET PRO | GET PRO | GET PRO |
| Net Debt/Equity | GET PRO | GET PRO | GET PRO |
| Total Debt/Assets | GET PRO | GET PRO | GET PRO |
| Total Assets/Equity | GET PRO | GET PRO | GET PRO |
| Liquidity + | |||
| Current Ratio | GET PRO | GET PRO | GET PRO |
| Quick Ratio | GET PRO | GET PRO | GET PRO |
| Interest Coverage | GET PRO | GET PRO | GET PRO |
| Performance | |||
| Gross Margin | GET PRO | GET PRO | GET PRO |
| Operating Margin | GET PRO | GET PRO | GET PRO |
| Net Margin | GET PRO | GET PRO | GET PRO |
| Return + | |||
| Return on Equity | GET PRO | GET PRO | GET PRO |
| Pre-tax ROCE | GET PRO | GET PRO | GET PRO |
| Return on Assets | GET PRO | GET PRO | GET PRO |
| Pre-tax ROIC | GET PRO | GET PRO | GET PRO |
| Efficiency + | |||
| Days Payable | GET PRO | GET PRO | GET PRO |
| Days Inventory | GET PRO | GET PRO | GET PRO |
| Days Receivable | GET PRO | GET PRO | GET PRO |
| Fixed Asset Turnover | GET PRO | GET PRO | GET PRO |
| Total Asset Turnover | GET PRO | GET PRO | GET PRO |
| Working Capital | |||
| Cash Conversion Cycle | GET PRO | GET PRO | GET PRO |
| Working Capital Days | GET PRO | GET PRO | GET PRO |
HDFC Bank Limited
No. of Loans: 1
Total Amount : 35.0 cr
| Designation | Name | DIN/PAN | Tenure |
|---|---|---|---|
| Director | Bajrang Dass Garg | 00008059 | 3 years |
| Director | Mridul Dhanuka | 00199441 | 4 years |
| Managing Director | Ashok Kumar Hegde | 06894537 | 4 years |
| Director | Phanindranath Ramachandran Punji | 08835296 | 3 years |
| CS | Sakthivel Ganapathy | <HIDDEN> | 2 years |
| Name | Status | Paid up Capital | Common Directors | Address |
|---|---|---|---|---|
| JINDAL ALUMINIUM ROLLING LIMITED |
Strike Off
|
9.0 L | 1 | Maharashtra |
| VARAMA SIR INDIA LOGISTIC AND INFRASTRUCTURE PRIVATE LIMITED |
Active
|
1.0 L | 1 | Delhi |
| NORTHERN MINERALS LIMITED |
Amalgamated
|
7.2 Cr | 1 | Delhi |
| M D BUILDTECH PRIVATE LIMITED |
Active
|
1.4 L | 1 | Delhi |
| DHANUKA INFOTECH PRIVATE LIMITED |
Strike Off
|
1.0 L | 1 | Delhi |
| DHANUKA CHEMICALS PRIVATE LIMITED |
Active
|
1.0 L | 1 | Delhi |
| ORCHID BIO-PHARMA LIMITED |
Active
|
15.0 Cr | 1 | Tamil Nadu |
| DHANUKA LABORATORIES LIMITED |
Active
|
13.8 Cr | 1 | Tamil Nadu |
| ORCHID PHARMA LIMITED |
Active
|
50.7 Cr | 1 | Tamil Nadu |
| NAVIEL BIO PHARMA SCIENCE PRIVATE LIMITED |
Active
|
5.6 L | 1 | Karnataka |
| NUWILL RESEARCH AND INNOVATIONS PRIVATE LIMITED |
Active
|
5.4 Cr | 2 | Karnataka |
The incorporation date of ORBION PHARMACEUTICALS PRIVATE LIMITED is 31 May, 2021
The authorized share capital of ORBION PHARMACEUTICALS PRIVATE LIMITED is INR ₹ 175.0 Cr.
The paid-up capital of ORBION PHARMACEUTICALS PRIVATE LIMITED is INR ₹ 175.0 Cr.
The registered address of ORBION PHARMACEUTICALS PRIVATE LIMITED is Plot B5 (Part) & Plot B6 (Part), Sipcot Industrial Park, Irrungatukottai, Sriperumbudur taluk Kanchipuram Chennai Tamil Nadu - 602117
The CIN number of ORBION PHARMACEUTICALS PRIVATE LIMITED is U24100TN2021FTC143806.
Expand
Delete
Collapse
See
details
